Search PDMR transactions

Notifier
Name of person with notification obligation
Anna Linton
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Anna Linton
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Pharmiva AB (publ)
Issuer´s LEI code
5493002PYGTLIBQYY395
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Pharmiva AB SE0015530670 Acquisition 18,940 Quantity 1.65 SEK 20/12/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Pharmiva AB SE0015530670 Acquisition 20/12/2022 NASDAQ STOCKHOLM AB 18,940 (Quantity) 1.65 SEK
Total: 18,940
<< Back